JP2024500115A5 - - Google Patents
Info
- Publication number
- JP2024500115A5 JP2024500115A5 JP2023536496A JP2023536496A JP2024500115A5 JP 2024500115 A5 JP2024500115 A5 JP 2024500115A5 JP 2023536496 A JP2023536496 A JP 2023536496A JP 2023536496 A JP2023536496 A JP 2023536496A JP 2024500115 A5 JP2024500115 A5 JP 2024500115A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- vector
- antibody fragment
- gene encoding
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20215823 | 2020-12-18 | ||
| EP20215823.4 | 2020-12-18 | ||
| PCT/EP2021/086645 WO2022129609A2 (en) | 2020-12-18 | 2021-12-17 | Antibody delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500115A JP2024500115A (ja) | 2024-01-04 |
| JP2024500115A5 true JP2024500115A5 (https=) | 2024-12-24 |
Family
ID=74183005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023536496A Pending JP2024500115A (ja) | 2020-12-18 | 2021-12-17 | 抗体デリバリー |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240100187A1 (https=) |
| EP (1) | EP4263573A2 (https=) |
| JP (1) | JP2024500115A (https=) |
| KR (1) | KR20230121096A (https=) |
| CN (1) | CN116917491A (https=) |
| AR (1) | AR124410A1 (https=) |
| AU (1) | AU2021399147A1 (https=) |
| CA (1) | CA3200807A1 (https=) |
| IL (1) | IL303758A (https=) |
| MX (1) | MX2023006973A (https=) |
| TW (1) | TW202242118A (https=) |
| WO (1) | WO2022129609A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4676596A1 (en) * | 2023-03-08 | 2026-01-14 | AC Immune SA | Anti-tdp-43 binding molecules and uses thereof |
| WO2025186332A1 (en) | 2024-03-05 | 2025-09-12 | Ac Immune Sa | Vectorized anti-tdp-43 antibodies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| DE69535243T2 (de) | 1994-07-13 | 2007-05-10 | Chugai Seiyaku K.K. | Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper |
| DK1069185T3 (da) | 1998-04-03 | 2011-06-27 | Chugai Pharmaceutical Co Ltd | Humaniseret antistof mod human vævsfaktor (TF) og fremgangsmåde til at konstruere humaniseret antistof |
| WO2015016786A1 (en) * | 2013-08-02 | 2015-02-05 | Agency For Science, Technology And Research | Mutated internal ribosomal entry site (ires) for controlled gene expression |
| CA2874083C (en) * | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
| KR20240005973A (ko) * | 2016-04-15 | 2024-01-12 | 리젠엑스바이오 인크. | 완전히-인간형의 번역후 변형된 항-VEGF Fab를 이용한 눈 질환의 치료 |
| US20190224339A1 (en) * | 2016-04-29 | 2019-07-25 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| EP3808849A1 (en) * | 2017-08-03 | 2021-04-21 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of aav |
| JP2022526018A (ja) * | 2019-04-11 | 2022-05-20 | カリフォルニア インスティテュート オブ テクノロジー | 脳内への特異性が増強されたウイルス組成物 |
-
2021
- 2021-12-17 CN CN202180084599.XA patent/CN116917491A/zh active Pending
- 2021-12-17 WO PCT/EP2021/086645 patent/WO2022129609A2/en not_active Ceased
- 2021-12-17 CA CA3200807A patent/CA3200807A1/en active Pending
- 2021-12-17 US US18/039,840 patent/US20240100187A1/en active Pending
- 2021-12-17 AU AU2021399147A patent/AU2021399147A1/en not_active Abandoned
- 2021-12-17 TW TW110147523A patent/TW202242118A/zh unknown
- 2021-12-17 IL IL303758A patent/IL303758A/en unknown
- 2021-12-17 KR KR1020237023349A patent/KR20230121096A/ko active Pending
- 2021-12-17 JP JP2023536496A patent/JP2024500115A/ja active Pending
- 2021-12-17 MX MX2023006973A patent/MX2023006973A/es unknown
- 2021-12-17 AR ARP210103555A patent/AR124410A1/es unknown
- 2021-12-17 EP EP21839551.5A patent/EP4263573A2/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023145597A (ja) | Ｒｎａを編集するための組成物および方法 | |
| JP4888876B2 (ja) | アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター | |
| US10787681B2 (en) | Humanized viral vectors and methods of use thereof | |
| JP2024500115A5 (https=) | ||
| JP2023523401A5 (https=) | ||
| JP2023504661A5 (https=) | ||
| US20230242602A1 (en) | Zinc finger protein transcription factors for repressing tau expression | |
| WO2022048446A1 (zh) | 用于病理性蛋白聚集物清除的嵌合抗原受体及其应用 | |
| JP2026031563A (ja) | 神経系における抗原結合タンパク質の発現 | |
| WO2021067864A1 (en) | Zinc finger protein transcription factors for treatment of prion disease | |
| JP2024500115A (ja) | 抗体デリバリー | |
| RU2831086C2 (ru) | Экспрессия антигенсвязывающих белков в нервной системе | |
| WO2025076091A1 (en) | Cd20 antibody aav vectors and methods of use thereof | |
| JP2024542015A5 (https=) | ||
| HK40103100A (zh) | 抗体递送 | |
| EP4615519A2 (en) | Treatment of neurological disorder using nhr | |
| SE2350348A1 (en) | Microglial endocytic receptors for use in the treatment of neurodegenerative disease | |
| TW202547548A (zh) | 使用血腦屏障穿透性蛋白殼之ｔａｕ抑制子遞送 | |
| Su et al. | Application to Gene Therapy and Vaccination |